REBECCA BARTLETT: Open Payments
NPI 1649792045 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 97 payments from 20 companies in 2025. Trend: 2023 $1,585 · 2024 $1,947 · 2025 $1,877
Food & beverage: $1,763Education: $114
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $277 |
| GENZYME CORPORATION | 12 | $265 |
| Galderma Laboratories, L.P. | 17 | $243 |
| Janssen Biotech, Inc. | 11 | $199 |
| Lilly USA, LLC | 12 | $191 |
| ABBVIE INC. | 11 | $158 |
| Novartis Pharmaceuticals Corporation | 5 | $94 |
| Incyte Corporation | 3 | $65 |
| Amgen Inc. | 3 | $58 |
| PFIZER INC. | 2 | $55 |
Products named: DUPIXENT, NEMLUVIO, TREMFYA, TALTZ, SKYRIZI, COSENTYX, RINVOQ, OPZELURA.
Industry payments across LA — which companies pay providers there.
